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The ability to generate appropriate defense responses is crucial for the survival of an organism exposed to pathogenesis-inducing
insults. However, the mechanisms that allow tissues and organs to cope with such stresses are poorly understood. Here we show
that caspase-3-knockout mice or caspase inhibitor-treated mice were defective in activating the antiapoptotic Akt kinase in re-
sponse to various chemical and environmental stresses causing sunburns, cardiomyopathy, or colitis. Defective Akt activation in
caspase-3-knockout mice was accompanied by increased cell death and impaired survival in some cases. Mice homozygous for a
mutation in RasGAP that prevents its cleavage by caspase-3 exhibited a similar defect in Akt activation, leading to increased
apoptosis in stressed organs, marked deterioration of their physiological functions, and stronger disease development. Our re-
sults provide evidence for the relevance of caspase-3 as a stress intensity sensor that controls cell fate by either initiating a
RasGAP cleavage-dependent cell resistance program or a cell suicide response.
Executioner caspases mediate cell death during apoptosis (45).Of these, caspase-3 has the ability to cleave the majority of the
caspase substrates (43), and its activity is required for the induc-
tion of cell death in response tomany apoptotic stimuli (1).While
executioner caspases are indispensable for apoptosis, there are sit-
uations when their activation does not lead to death. For example,
healthy dividing cells can weakly activate caspase-3 in response to
mild stresses (47). Caspase-3 also participates, in an apoptosis-
independent manner, in T and B cell homeostasis (35, 46), in
microglia activation (6), in long-term depression (26), and in
muscle (17), monocyte (44), embryonic stem cell (18), and ery-
throid cell (13) differentiation. However, it remains unclear how
activation of caspase-3 under these conditions does not eventually
lead to cell death (1, 24). Cells could have an intrinsic ability to
tolerate low caspase activity by constitutively expressing antiapo-
ptotic molecules, such as members of the inhibitors of the apop-
tosis protein family, or may stimulate antiapoptotic pathways in
parallel to caspase activation (24). Alternatively, the caspases
themselves might activate prosurvival pathways, in particular,
when they are mildly stimulated. Indeed, there is evidence in cul-
tured cells that caspase-3 mediates neuroprotection after precon-
ditioning (30) and that caspase-3 activity turns on the antiapop-
totic Akt kinase following partial cleavage of the RasGAP protein
(47). Other caspase substrates that could potentially induce pro-
tective signals once cleaved include p27kip1 (14), Lyn (28), synphi-
lin-1 (19), and Rb (42), yet the physiological importance of these
cleaved substrates has not been evaluated to date.
In the present study, we have investigated the role played by
caspase-3 and its substrate p120 RasGAP in the induction of the
antiapoptotic Akt kinase in stressed tissues in vivo.
MATERIALS AND METHODS
Caspase-3-KO mice. B6.129S1-Casp3tm1Flv/J caspase-3-knockout (KO)
micewere purchased from the Jackson Laboratory (BarHarbor,ME). The
mice were genotyped using a mixture of the following three oligonucleo-
tides: wild-type sense (GCG AGTGAGAATGTGCAT AAA TTC), wild-
type antisense (GGGAAACCAACAGTAGTCAGTCCT), and caspase-
3-knockout antisense (TGC TAA AGC GCA TGC TCC AGA CTG). The
sizes of the amplified fragments are 320 bp for the wild-type allele and 300
bp for the caspase-3-knockout allele.
Generation of RasGAPD455A-knock-in (KI)mice. The strategy and
methods used to create the targeting vector are presented in Fig. S1 in the
supplemental material.
UV-B exposure and isolation of skin samples.Mice were shaved on
both flanks, followed by depilationwith depilatory cream (Veet), and 48 h
later were anesthetized and illuminated with a Waldmann UV801 KL
apparatus equippedwith a PhilipsUV21UV-B lamp (TL 20W/12RS). The
doses of UV-B illumination were 0.05 and 0.3 J/cm2 (i.e., 50 mJ/cm2
and 300 mJ/cm2, respectively), which were measured with a Waldmann
Variocontrol dosimeter. In each case, only one side of the mouse was
illuminated and the other side was used as a control (i.e., nonexposed
skin). Mice were sacrificed 24 h after illumination. The lateral skin biopsy
specimens (approximately 2 by 2 cm)were excised fromeachmouse, fixed
in phosphate-buffered saline (PBS) and 4% Formol solution, and embed-
ded in paraffin. The paraffin-embedded skin was cut into 4-m sections,
deparaffinized, and stained with hematoxylin-eosin for histological ob-
servation.
Doxorubicin injection and hemodynamic measurements using left
ventricular PV microcatheters. Eight-week-old mice were weighed and
injected with a single intraperitoneal doxorubicin dose of 20 mg/kg of
body weight using a 2-mg/ml doxorubicin solution (catalog number
733857-01; EBEWE Pharma) or injected with an equal volume of saline
(catalog number 534534; B. Braun Medical AG). At 5 days postinjection,
the animals were weighed again (the weight loss at that time was between
10 and 15%). The animals were anesthetized with an intraperitoneal in-
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jection of 75 mg/kg ketamine and 10 mg/kg xylazine (the volume of in-
jection was 10 l per g of mouse). A pressure-volume (PV) SPR-839
catheter (Millar Instruments, Houston, TX) was inserted into the left
ventricle (LV) via the right carotid artery. After stabilization for 20 min,
heart rate, LV systolic and end-diastolic pressures, and volumesweremea-
sured, and stroke volume, ejection fraction, and cardiac output were cal-
culated and corrected according to in vitro and in vivo volume calibrations
with a cardiac PV analysis program (PVAN3.2; Millar Instruments) (38,
39). End-systolic LV PV relationships were assessed by transiently reduc-
ing venous return by compressing the inferior vena cava, and LV contrac-
tility was assessed from the slope of the LV end-systolic PV relationship
(end-systolic elastance), calculated using PVAN3.2, as detailed previously
(21, 38). Hearts were isolated, cut into two pieces, and then either snap-
frozen or fixed in 4% formalin for histology studies.
DSS-induced colitis and clinical score. Eight-week-old mice were
given acidified water supplemented with 5% (wt/vol) dextran sodium
sulfate (DSS; molecular weight, 400,000 to 600,000; MP Biomedicals,
Illkirch, France) for 72 h and then given normal drinking water for four
additional days. Mice were examined daily, and body weight, water con-
sumption, occult blood, and diarrhea weremeasured. At day 7, mice were
sacrificed, the colon length was measured, and a clinical score was esti-
mated according to the procedure described by Ohkawara et al. (36).
Percentage of weight loss was calculated by comparing the weight at day 0
and the weight of the mice at sacrifice. Scores were given according to
the extent of weight loss: 0, no weight loss; 1, 1 to 5%; 2, 5 to 10%; 3, 10
to 15%; 4, 15%. Diarrhea was scored using a scale with values rang-
ing from 0 to 4: 0, normal; 1, slightly loose feces; 2, loose feces; 3, semi-
liquid stool; and 4, liquid stool. Fecal occult blood was detected using
guaiac paper (ColoScreen Hemocult kit; Helena Labs, Beaumont, TX),
and the associated scores were as follows: 0, none; 2, positive Hemocult
result; and 4, gross bleeding. Colons were cut into three equal portions
(proximal,middle, and distal), and each portionwas further cut into three
equal parts, two of which were snap-frozen in liquid N2 and stored at
80°C for subsequent protein and RNA analysis, and the third portion
was fixed in 4% formalin for histology analysis (paraffin sections).
Quantitation of active Akt- and active caspase-3-positive cells in
heart, skin, and colon. Sections stained as described in the previous sec-
tions were scanned using an automated Nikon Eclipse 90i microscope
equipped with Apo Plan 20 (0.75 pH 2 PM) and Apo Plan 40/1.0
DIC-H objectives and piloted with NIS-Elements Advance Research soft-
ware (Nikon Instruments Inc., Melville, NY).
Three whole-heart sections were scanned at different levels, and the
corresponding whole-section images were generated. The number of
pAkt-positive cells was scored manually by counting the number of cells
stained with the anti-phospho-Akt antibody (the samples were random-
ized prior to examination, and the person performing the counting was
not aware of the experimental conditions). The total number of cells was
determined by automatically scoring the number of nuclei (stained with
the Hoechst 33342 dye) using the NIS-Elements AR program (Nikon). In
order tominimize errors, all images were acquired with the same contrast
(high), size and quality (1280  960 pixels), exposure time (4=,6-di-
amidino-2-phenylindole [DAPI], 40 ms; fluorescein isothiocyanate
[FITC], 300 ms), and gain (1). The quantification threshold in the au-
tomated measurement menu was set at L32 for low and H236 for high,
and the area was restricted to 0 to 0.5 m2 out. In the image menu, the
local contrast was set to 30, and in the image-background option, the
background was set to 40 for DAPI and to 999 for FITC. Using the binary
menu, the holes were filled using the fill holes option. This was performed
to avoid multiple counting of the same nucleus. Touching nuclei were
separated using the morpho separate objects option. The number of nu-
clei was displayed under automated measurement results—object data.
Skin sections were scanned and analyzed similarly. Fifteen different fields
were randomly taken from the proximal,middle, and distal sections of the
colon and processed and analyzed as described above.
Apoptosis scoring. Apoptosis on histological slides was assessed by
terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end la-
beling (TUNEL) assay (DeadEnd Fluorometric TUNEL system; catalog
number G3250; Promega Switzerland), as per the manufacturer’s proto-
col, and quantitated as described for the Akt staining in the previous
section. Apoptosis in vitro countingwas assessed by scoring the number of
cells with pycnotic or fragmented nuclei after Hoechst 33342 staining
(48).
Chemicals and antibodies. The quinolyl-valyl-O-methylaspartyl-
[2,6-difluorophenoxy]-methyl ketone (Q-VD-OPh) caspase inhibitor
was from MP Biomedicals (catalog number OPH109). Hexameric FasL
(fusion protein between the Fas ligand and the Fc portion of IgG1) (20)
was a kind gift from Pascal Schneider (University of Lausanne). The
monoclonal and polyclonal anti-phospho-Ser473 Akt antibodies and the
cleaved caspase-3-specific antibody were from Cell Signaling Technology
(catalog numbers 4051, 9271, and 9664, respectively). The monoclonal
anti-phospho-Ser473 Akt antibody was used on skin and colon sections as
well as for Western blot assays, while the polyclonal anti-phospho-Ser473
Akt antibody was used on heart sections. The antibody recognizing total
Akt was from Santa Cruz (catalog number sc-8312). The anti-RasGAP
antibody was from Enzo Life Science (catalog number ALX-210-860-
R100). Secondary antibodies (Cy3-coupled donkey anti-rabbit, horserad-
ish peroxidase [HRP]-coupled donkey anti-rabbit, and HRP-coupled
donkey anti-mouse antibodies) were from Jackson Immunoresearch (cat-
alog numbers 711-165-152, 715-035-152, and 715-035-150, respectively).
Protein extraction. Snap-frozen skin (0.3-cm2 biopsy specimens),
heart, and intestine tissue samples were crushed into powder in liquid
nitrogen-dipped mortar and pestle and then suspended in 700 l lysis
buffer (Tris-HCl, 50mM; EDTA, 1mM; EGTA, 1mM; Triton X-100, 1%;
dithiothreitol, 1 mM; sodium pyrophosphate, 5 mM; NaF, 50 mM; pro-
tease inhibitor cocktail tablet [1 tablet/40 ml buffer; catalog number 04
693 132 001; Roche]; phenylmethylsulfonyl fluoride, 1 mM; glycerol,
10%; pH 7.4). The samples were sonicated (amplitude, 80%; 5 s; twice).
Protein concentration was measured by the Bradford assay using bovine
serum albumin (BSA) as a standard. Lysates were mixed with an equal
volume of 2 sample buffer (100 mM Tris-HCl [pH 6.8], 20% glycerol,
10% [vol/vol] -mercaptoethanol, 4% [wt/vol] sodium dodecyl sulfate
[SDS], and 0.02%bromophenol blue) and boiled for 5min at 95°C before
loading on SDS-polyacrylamide gels.
Western blotting.Western blottingwas performed and quantitated as
described previously (31).
Preparation of tissue section and immunohistochemistry. Mice
were euthanized by cervical dislocation. The isolated organs (heart, skin,
or intestine) were stored in PBS–4% Formol solution and embedded in
paraffin. Four-micrometer sections were deparaffinized in toluene (cata-
log number 488555; Carlo Erba, Milan, Italy) and rehydrated using
graded alcohol and distilled water. Antigen retrieval was performed by
immersing sections in sodium citrate buffer (10 mM sodium citrate, pH
6), followed by heating in a microwave oven for 20 min (8 min at 800 W
and 12 min at 400 W). Sections were cooled to room temperature and
blocked using a 50 mM Tris-HCl, pH 7.6, 0.5% Tween 20, 0.2% BSA
solution. The primary antibody was diluted (pAkt, 1/100; cleaved
caspase-3, 1/200) in 50 mM Tris-HCl, pH 7.6, 0.5% Tween 20, 0.2% BSA
and incubated with the slides for 1 h. Slides were washed 2 times for 10
min each time in 50 mM Tris-HCl, pH 7.6, 0.5% Tween 20. The fluoro-
chrome-conjugated secondary antibody (Jackson Laboratory), diluted
1:300 in 50 mM Tris-HCl, pH 7.6, 0.5% Tween 20, 0.2% BSA, was incu-
bated with the slides for another hour in the dark. Slides were then exten-
sively washed (at least 6 times with one overnight washing step). The
nuclei in the sections were then stained with 10 g/ml Hoechst 33342.
Finally, the slides were mounted in Mowiol (catalogue number 81381;
Fluka) at a concentration of 0.1mg/ml in a solutionmade of 20% glycerol
and 0.1%DABCO (diazobiciclo-octane; catalogue number 33480; Fluka).
Immunohistochemistry with tyramide signal amplification. Tyra-
mide amplification of immunohistochemical signals using phospho-Akt-
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specific antibodies was performed as described earlier (4). The primary
antibody and the secondary HRP-coupled antibody were diluted 1/100
and 1/1,000, respectively.
Ethics statement. Experiments on the mice were carried out in strict
accordance with the Swiss Animal Protection Ordinance (OPAn). The
protocol was approved by the Veterinary Office of the state of Vaud,
Switzerland (permit numbers 2055, 2056, and 2361).
MEF preparation.Mouse embryonic fibroblasts (MEFs) from KI and
wild-type mice were initially prepared as described earlier by digesting
embryonic day 14 embryos for 1.5 h in 0.05% trypsin (5). Using this
protocol, MEFs could be generated from wild-type embryos, but none
were obtained from the KI embryos (Fig. 5C). Reducing the incubation
time in trypsin to 15 min, which presumably lessened a stressful situation
on cells, however, allowed production of both wild-type and KI MEFs in
more or less similar numbers (Fig. 5C).
Statistics. SAS/STAT (version 9.1) software (SAS Institute Inc., Cary,
NC) was used to perform the statistical analyses. Unless otherwise stated,
one-way analyses of variance were performed to determine the signifi-
cance of the observed differences presented in the figures. Asterisks and
NS in the figures indicate significant differences (P 0.05) and no signif-
icant differences, respectively.
RESULTS
Mice lacking caspase-3 are impaired in their capacity to activate
Akt in response to stress. Akt (also called PKB) is a downstream
effector of phosphatidylinositol 3-kinase (PI3K) thatmediates the
survival responses of many cell types and tissues (40) and as such
could be involved in stress survival responses across most, if not
all, tissues. To determine whether Akt is activated in various tis-
sues and organs in response to pathology-inducing stresses, mice
were exposed to three different challenges: exposure of the skin to
UV-B, injection of doxorubicin (an anticancer drug inducing car-
diomyopathy), and administration of dextran sodium sulfate
(DSS) via drinkingwater to induce colitis. In control skin, very few
keratinocytes (0.25%) expressed the active phosphorylated
form of Akt (Fig. 1A). In response to mild UV-B exposure (0.05
J/cm2), more than 10% of the keratinocytes had active Akt in their
cytoplasm (Fig. 1A). In the hearts of untreatedmice, cells express-
ing activated Akt were readily observed. Virtually all of these cells
were cardiomyocytes, as determined by their shape and nucleus
location (Fig. 1B). Under basal conditions (i.e., no treatment), the
percentage of cells with active Akt was much higher in the heart
(6%) than in the epidermis. Doxorubicin increased the percent-
age of Akt-positive cardiomyocytes in a statistically significant
manner to 10% (Fig. 1B, gray bars). Akin to the situation en-
countered in the skin, very few cells in the colon epithelium
(0.7%) were found to be positive for active Akt (Fig. 1C). This
percentage significantly increased to 1.2% when colitis was in-
duced by DSS (Fig. 1C, gray bars).
To determine whether Akt activation was dependent on
caspase-3, we analyzed caspase-3-KO mice on the C57BL6 back-
ground . In this background, caspase-3-KOmice reach adulthood
and breed (25).When the skin of thesemicewas exposed toUV-B,
the number of keratinocytes with active Akt increased (Fig. 1A,
lower right), suggesting that a caspase-3-independent mechanism
can participate in the induction of protective signals in the epider-
mis. However, the UV-B-induced increase in the percentage of
active Akt-positive keratinocytes in caspase-3-KOmice wasmuch
reduced compared to the situation observed in wild-type mice,
and the increase was not statistically significant (Fig. 1A, black
bars). This indicates that caspase-3 is required for a maximal Akt
response in keratinocytes subjected to UV-B illumination. When
caspase-3-KO mice were treated with doxorubicin or DSS, the
percentage of cells with active Akt in the targeted organs did not
change compared to the nonchallenged situation (compare the
gray and black bars in Fig. 1B and C), indicating that caspase-3 is
strictly required for Akt activation in these tissues exposed to
stress. To determine if stimulation of caspase-3 activity and not
some other noncatalytic functions of the protease is necessary for
stress-induced Akt activation, wild-type mice were injected with
Q-VD-OPh, a broad-spectrum caspase inhibitor (10). Figures 2A
and B show that this compound inhibited UV-B-induced
caspase-3 activation in the skin. Q-VD-OPh was found to signif-
icantly decrease the ability of epidermal cells to stimulate Akt in
response to UV-B (Fig. 2C), indicating that activation of caspases
FIG 1 Defective stress-induced Akt activation in mice lacking caspase-3. The
indicated numbers of wild-type (WT) and caspase-3-knockout (C3 KO) mice
were subjected or not subjected to illumination of their skin with 0.05 J/cm2
UV-B (A; 2 independent experiments), injection of 20 mg/kg doxorubicin
(DOXorDoxo) (B; 2 independent experiments), or exposure to 5%DSS in the
drinking water (C; 3 independent experiments) (see Materials and Methods
for details). (A to C) Histological sections of the organs and tissues targeted by
these stresses were then stained with an antibody recognizing the active phos-
phorylated form of Akt, and the percentage of phospho-Akt (pAkt)-positive
cells was quantitated. Results correspond to the mean 95% CI. The images
shown are representative examples of sections labeled with the anti-phospho-
Akt antibody (red or green staining) and with Hoechst 33342 (blue staining of
the nuclei). Bars, 20 m.
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is required for the induction of the antiapoptotic Akt kinase in
response to stress.
Increased stress-induced cell death and cell damage in mice
lacking caspase-3. Impaired Akt activation in caspase-3-knock-
out mice may not lead to visible damage of the targeted tissues if
the absence of caspase-3 prevents implementation of a cell death
response. There are indeed situations where caspase-3 is manda-
tory for cell death. For example, beta cells from caspase-3-KO
mice are fully resistant against streptozotocin-induced death,
while beta cells from wild-type mice are not, leading to the devel-
opment of diabetes (27). In other situations, cell death may still
occur in the absence of caspase-3, either as a result of a nonapop-
totic type of death or because apoptosis is mediated by other exe-
cutioner caspases (e.g., caspase-7). In such cases, the absence of a
caspase-3-mediated Akt activationmight have detrimental conse-
quences. To assess this point, we monitored the extent of stress-
induced cell death in the skin and the heart of caspase-3-KO and
wild-type mice.
In the skin of wild-typemice, UV-B induced the appearance of
keratinocytes with a pycnotic nucleus and densely staining glassy
cytoplasm—the so-called sunburn cells (see the inset in the lower
left-hand panel in Fig. 3A)—which are apoptotic cells character-
istic of those in damaged skin following UV exposure (12). The
percentage of sunburn cells generated by UV-B in the skin of
caspase-3-KOmice was significantly reduced compared to that in
the skin of wild-type mice (Fig. 3A). Similarly, there were fewer
TUNEL-positive keratinocytes in the UV-B-illuminated skin of
caspase-3-KO mice than in the skin of wild-type mice (Fig. 3B).
This indicates that caspase-3 is a mainmediator of UV-B-induced
keratinocyte apoptosis. Cells can also die in a necrosis-like, nonapo-
ptotic manner, in particular, when apoptosis pathways are altered
(41). Keratinocytes dying in this way are characterized by their
irregular shape, an eosinophilic cytoplasm, and hyperchromatic,
condensed, and partly fragmented nuclei (3) (see the inset in the
lower right-hand panel in Fig. 3A). UV-B dramatically increased
the percentage of keratinocytes undergoing this type of death in
the skin of caspase-3-KO mice compared to the skin of wild-
type mice (Fig. 3A). When accounting for both apoptosis and
necrosis-like deaths, there was more UV-B-mediated death re-
corded in the skin of caspase-3-KO mice than in the skin of
wild-type mice (8.1%  2.5% versus 4.9%  1.2%; mean 
95% confidence interval [CI]).
Doxorubicin is a DNA-intercalating drug that induces both
caspase-dependent and -independent cell death in various cell
types (29), including cardiomyocytes (51). In response to doxo-
rubicin injection, the percentage of cardiomyocytes undergoing
apoptosis, as assessed with the TUNEL assay (see a representative
example on the left-hand side of Fig. 3C), was significantly higher
in caspase-3-KO mice than wild-type mice (Fig. 3C). It therefore
appears that apoptosis induced by doxorubicin can be mediated
by executioner caspases other than caspase-3, which is consistent
with the observation that doxorubicin efficiently activates
caspase-7 (11).
The increased susceptibility of caspase-3-KO mice to doxoru-
bicin-induced cardiomyocyte apoptosis raised the possibility that
the lack of caspase-3 affects survival of mice treated with doxoru-
bicin. Figure 3D shows that caspase-3-KOmice survived doxoru-
bicin treatment less efficiently than wild-type mice. This suggests
that caspase-3 mediates a protective response in doxorubicin-
treated animals that is required to counteract tissue damage in-
duced in a caspase-3-independent manner.
In conclusion, the results presented in Fig. 1 to 3 show that,
upon stress exposure, mice lacking caspase-3 are defective in the
activation of the prosurvival Akt kinase and that this correlates
with increased cell death, tissue damage, and even death of the
animals.
Generation ofmice expressing a caspase-3-resistant RasGAP
mutant. In vitro, low caspase-3 activity leads to the cleavage of the
p120 RasGAP protein into an amino-terminal fragment, called
fragment N, that stimulates Akt in a Ras/PI3K-dependentmanner
(47, 50), preventing further caspase-3 activation and apoptosis
(47). In the presence of high caspase-3 activity, fragment N is
further cleaved into two additional fragments (fragments N1 and
N2) that are unable to activate Akt (48). Notably, this second
cleavage event does not take place if the first cleavage is prevented
(49). Further, in the absence of caspase-3 in cells, other execu-
tioner caspases, such as caspase-6 and caspase-7, cannot cleave
RasGAP (47). RasGAP is therefore a specific caspase-3 substrate. To
assess the role of fragment N in Akt stimulation in stressed organs,
we generated a KI mouse in which the first RasGAP cleavage site
recognized by caspase-3 was destroyed by an aspartate-to-alanine
substitution at position 455 (DTVA[455]G) (Fig. 4A and B); the
construction of the targeting vector is shown in Fig. S1 in
the supplemental material, and genetic analyses of the resulting
mice are shown in Fig. 4B andC. Thismutation does not affect the
function of full-length RasGAP (47). Mice homozygous for the
RasGAPD455A allele (KImice) are viable and fertile, grow normally
(Fig. 4D), and show no obvious morphological alterations (Fig.
4E), histologic defects (data not shown), or hematologic abnor-
FIG 2 Pharmacological inhibition of caspases hampers UV-B-induced Akt
activation in the epidermis.Wild-typemice were injected or not with 50mg of
the Q-VD-OPh caspase inhibitor per kg of mouse 15 min prior to UV-B ex-
posure of the skin (0.3 J/cm2 [A and B] and 0.05 J/cm2 [C]). (A) Levels of
cleaved active caspase-3, full-length inactive caspase-3, and actin were assessed
by Western blotting. This experiment was repeated once with similar results.
(B) Levels of active caspase-3 in situ were also visualized by immunofluores-
cence. Bar, 20 m. The pictures are representative images of data obtained
with three mice per condition. (C) Levels of phosphorylated Akt were assessed
as described in Fig. 1. Results correspond to the mean 95%CI of 3 indepen-
dent experiments (n	 3).
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malities (see Table S1 in the supplementalmaterial). Expression of
RasGAP, caspase-3, Akt, and actin was similar in given tissues and
cells derived from wild-type and KI mice (Fig. 4F). The transmis-
sion of themutated alleles occurredwith normalMendelian ratios
(among 317 offspring obtained from breeding heterozygote

/D455A mice, 22.4% were 
/
, 54.3% were 
/D455A, and
23.7% were D455A/D455A).
As expected, fibroblasts derived from KI embryos were unable
to cleave RasGAP in response to various apoptotic stimuli
(Fig. 5A) and were more prone to apoptosis in response to these
stimuli than control MEFs (Fig. 5B). Additionally, in contrast to
what was observedwithwild-type embryos, cells fromKI embryos
did not survive long-term trypsin digestion (Fig. 5C). MEFs from
KI embryos were also impaired in their capacity to activate Akt in
response to stress (Fig. 5D). The increased susceptibility of KI cells
to death in response to stresses is consistent with the known ability
of fragment N to stimulate Akt and inhibit apoptosis in cultured
cell lines (47, 49, 50).
Mice that cannot cleaveRasGAPatposition455 areunable to
activate Akt in response to stress, and they experience increased
apoptosis, tissue damage, and organ dysfunction. The KI mice
were thenused to assess the importance of RasGAP cleavage inAkt
activation and in the protection of tissues and organs upon expo-
sure to the pathophysiological challenges described for Fig. 1. In
response to low UV-B exposure (0.05 J/cm2), Akt was activated in
about 10% of keratinocytes of wild-type mice (Fig. 6A). Akt acti-
vation was, however, not observed when the skin was exposed to
higher UV-B doses (0.3 J/cm2) (Fig. 6A) that led to strong
caspase-3 activation (Fig. 6B). It is known that low caspase-3 ac-
tivity leads to fragmentN generation, while high caspase-3 activity
induces fragment N cleavage into fragments that are no longer
able to activate Akt (48). In skin samples, all the RasGAP antibod-
ies that we have tested lit up bands in the 35- to 55-kDa range,
precluding visualization of fragment N (52 kDa) (Fig. 6C). These
bands may be nonspecifically recognized by the RasGAP antibod-
ies, but it is more likely that they correspond to RasGAP degrada-
tion products that are generated in keratinocytes en route to their
final differentiation stage in the cornified layer, a process that is
known to be associated with massive activation of epidermal pro-
teases (8). Fragment N2, one of the caspase-3-generated products
of fragment N (49), was, however, seen in samples derived from
skin exposed to 0.3 J/cm2 UV-B but not in samples derived from
skin exposed to 0.05 J/cm2 UV-B (Fig. 6C). These results indicate
that Akt is not activated under conditions where fragment N2 is
produced, i.e., when fragment N is degraded. In contrast to what
was observed inwild-type skin, lowdoses ofUV-Bonlymarginally
FIG3 Increased stress-induced cell death and cell damage inmice lacking caspase-3. (A)Histological assessment of sunburn (black arrow) and necrotic-like (red
arrows) cells in the epidermis (left and middle) of UV-B (0.05-J/cm2)-irradiated mouse skin. Results correspond to the mean  95% CI of measurements
performed on 3 and 8 control and irradiated animals, respectively. Bar, 20m. (B) Quantitation of TUNEL-positive keratinocytes following UV-B (0.05-J/cm2)
irradiation. Results correspond to the mean 95% CI (3 animals per condition). (C) Apoptosis assessment by the TUNEL assay in cardiomyocytes from mice
injected with 20mg/kg doxorubicin 5 days earlier. A representative example of an apoptotic cardiomyocyte is shown on the left. Bar, 10m. Results correspond
to the mean 95% CI (3 animals per condition). (D) Survival curves of 6 wild-type and 7 caspase-3-KOmice injected with 20 mg/kg doxorubicin (8 wild-type
and 11 caspase-3-KO mice were used in the control noninjected groups). A Wilcoxon test of equality over strata (life-test procedure) was used to assess the
significance of the observed difference.
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and nonsignificantly activated Akt in keratinocytes from KI skin
(Fig. 6A). This correlated with increased numbers of cells express-
ing active caspase-3 (Fig. 6B) and cells undergoing apoptosis (Fig.
6D). When the skin was exposed to higher UV-B doses (0.3
J/cm2), the extent of apoptosis in the skin ofwild-type andKImice
was not significantly different, although there was a trend of a
stronger apoptotic response in KI mice (Fig. 6D) that correlated
with a tendency of KI mice to activate less Akt (compare the last
two bars in Fig. 6A) but more caspase-3 (Fig. 6B) at high UV-B
doses. Sunburn cells (see the example in Fig. 6E) were significantly
augmented in the epidermis of 0.05-J/cm2 UV-B-exposed KI skin
compared to wild-type skin (Fig. 6E). The observed difference at
higher UV-B doses (0.3 J/cm2) was, however, not statistically sig-
nificant.
Doxorubicin induced the cleavage of RasGAP into fragment N
in the heart of wild-type mice (Fig. 7A). As expected, this was not
observed in KI mice (Fig. 7A). Following doxorubicin injection,
the number of cardiomyocytes with activated Akt did not increase
in KI mice (Fig. 7B). This was also associated with an increase in
the number of apoptotic cells in the heart (Fig. 7C). In response to
doxorubicin, KImice hadmore impaired cardiac function asmea-
sured by hemodynamic parameters (see Table S2 in the supple-
mental material). Specifically, end-systolic elastance, which is de-
rived from end-systolic pressure volume curves (Fig. 7D) and
which is a direct (load-independent) measure of the heart con-
tractile activity, was significantly decreased inKImice treatedwith
doxorubicin (Fig. 7D and E).
Finally, enterocytes from KI mice were also affected in their
FIG4 Generation of RasGAPD455A/D455A knock-inmice. (A) The targeting vector consists ofmouse RasGAP exons 9, 10, and 11. Exon 10 (indicated in red) bears
the RasGAPD455Amutation. E, X, and B, EcoRV, XhoI, and BamHI, respectively; gray bars below the alleles, length of the BamHI/EcoRV fragments recognized
by the probe (black bar) when genotyping by Southern blot is performed. (B) Detection of the D455A allele by PCR. The D455A allele bears a new NgoMIV
restriction site encompassing the aspartate-to-alanine mutation (in red) within the caspase recognition site in RasGAP (in green). Genomic DNAwas subjected
to PCR amplification using primers flanking exon 10. The amplified fragments, after digestion with NgoMIV or not, were separated on a 1.5% agarose gel. The
presence of theD455Amutation results in cleavage of the600-bpPCR fragment into two comigrating300-bp fragments. (C) Tail-purified genomicDNAwas
digested with EcoRV and BamHI and tested by Southern blotting using the probe shown in panel A. (D) The body weight of wild-type and RasGAPD455A/D455A
knock-inmales wasmonitored at the indicated time points. Results correspond to themean 95%CI of at least 9 determinations per condition. (E) Images from
anesthetized 10-week-old mice. (F) The expression of RasGAP, caspase-3, Akt, and actin in the indicated cell type and tissues was assessed by Western blotting.
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capacity to activate Akt in response to DSS (Fig. 8A), and this was
accompanied by an increased apoptotic response compared to
what was seen in wild-type mice (Fig. 8B). At the clinical level,
DSS-induced colon damage was more pronounced, as assessed by
colon shortening (Fig. 8C) and a more severe DSS-mediated coli-
tis development in KI mice than wild-type mice (Fig. 8D).
DISCUSSION
The role of caspase-3 in the induction of the antiapoptotic Akt
kinase was investigated in adult caspase-3-knockout mice in rela-
tion to three different pathophysiological conditions: UV-B skin
exposure, doxorubicin-induced cardiomyopathy, andDSS-medi-
ated colitis. Each of these stresses led to Akt activation in the tis-
sues affected by the stress. This was, however, blocked or strongly
compromised in mice lacking caspase-3. This impaired Akt acti-
vation correlated with augmented cell death, tissue damage, and
even lethality. A similar defect inAkt activationwas observed inKI
mice that expressed a caspase-3-resistant form of p120 RasGAP,
and this was accompanied by increased apoptosis and stronger
adverse effects: increased number of sunburn cells in UV-B-ex-
posed skin, decreased heart function upon doxorubicin injection,
and strongerDSS-mediated colitis development. This study there-
fore identifies a physiological protective mechanism against stress
that relies on the activity of an executioner caspase.
Caspase-3 is now known to mediate many nonapoptotic func-
tions in cells (15, 23, 24). It is involved in B cell homeostasis by
negatively regulating B cell proliferation following antigen stimu-
lation (46). Caspase-3 is also activated during T cell stimulation
(32), and this may participate in T cell proliferation (2, 22). Addi-
tionally, caspase-3 is required for erythropoiesis (9). There is thus
evidence that caspase-3 plays important functional roles in non-
dying hematopoietic cells, but it remains unclear how these cells
counteract the apoptotic potential of caspase-3. Cleavage of
RasGAP could have been one of the mechanisms allowing these
cells to survive following caspase-3 activation. However, T and B
cell development occurs normally in the D455A RasGAP KI mice
(see Table S1 in the supplemental material). Similarly, the devel-
opment of mature myeloid and erythroid lineage cells in the bone
marrow proceeds normally in the KI mice (see Table S1 in the
supplemental material). Therefore, hematopoietic cells use pro-
tective mechanisms other than those activated by the cleavage of
RasGAP to inhibit apoptosis if caspase-3 is activated during their
development.
Caspase-3 is necessary for the development of several tissues.
FIG 5 MEFs from RasGAPD455A/D455A knock-in mice do not cleave RasGAP and are more sensitive to apoptosis. (A and B)Wild-type (WT) and KI MEFs were
left untreated () or treated with 15Mcisplatin (Cis), 96 J/m2UV-C (UV), 15 ng/ml FasL (F), and 15 nM staurosporine (St). (A) Cells were lysed 24 h later and
analyzed byWestern blotting for the presence of RasGAP and its fragments using an anti-RasGAP polyclonal antibody. (B) Alternatively, apoptosis was scored.
Results correspond to the mean 95% CI of 3 independent experiments (n	 3). (C) Mouse embryonic cells 1 day after their isolation using a trypsinization
period of 1 h 30 min or 15 min (see Materials and Methods for details). (D) Wild-type and KI MEFs were treated with 5 ng/ml FasL for the indicated periods of
time. Cells were then washed twice with PBS and then incubated for an additional hour in Dulbecco modified Eagle medium at 37°C before lysis. Akt activation
and total Akt expression were assessed by Western blotting. Lane M, molecular mass markers.
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Muscle development and osteoblast differentiation are compro-
mised in the absence of caspase-3 (17, 33, 34). Caspase-3 also plays
important functions in neurogenesis, synaptic activity, neuronal
growth cone guidance, and glial development (7, 16, 37). Histo-
logical analyses of muscle, bone, and brain tissues did not reveal
any defect in theKImice (data now shown).Moreover, the growth
curve and size of wild-type and KImice were comparable (Fig. 4D
and E). Hence, the mechanisms allowing tissues and organs to
withstand caspase-3 activation during development do not rely on
RasGAP cleavage and remain to be characterized.
In vitro data provided evidence that low caspase-3 activity in-
duced bymild stress generates fragment N, which was responsible
for Akt activation and promotion of cell survival. At higher
caspase-3 activity induced by stronger insults, fragment N is fur-
ther processed into fragments that can no longer stimulate Akt,
and this favors apoptosis (47). The data obtained in vivo in UV-
B-exposed skin are consistent with thismodel. Low doses of UV-B
induced no further cleavage of fragment N (i.e., no production of
fragment N2) in keratinocytes, and this was accompanied by Akt
activation and absence of an apoptotic response. In contrast, high
UV-B doses generated fragment N2 and Akt was no longer acti-
vated, and this led to keratinocyte cell death (Fig. 6). In vivo, there-
fore, RasGAP also functions as a caspase-3 activity sensor to de-
termine whether cells within tissues and organs should be spared
or die.
The levels of caspase-3 activation that are required to induce
partial cleavage of RasGAP into fragment N are at least an order of
magnitude lower than those necessary to induce apoptosis (48). In
vitro, these low caspase activity levels are not easily detected (47).
In response to the stress stimuli used in the present study that led
to Akt activation, we could not visualize low caspase-3 activation
byWestern blotting in any of the tissues investigated, although in
response to stronger stresses that did not lead to Akt activation
(e.g., 0.3 J/cm2 of UV-B [Fig. 6]), caspase-3 activation could be
evidenced (Fig. 2A and B). Nonetheless, blocking caspases with
chemical inhibitors or usingmice lacking caspase-3 preventedAkt
FIG 6 Role of RasGAP cleavage in UV-B exposed skin. Skin of wild-type (WT) and RasGAPD455A/D455A (KI) mice was exposed to the indicated doses of UV-B.
Mice were sacrificed 24 h later, and the exposed skin was isolated for biochemical and histological analyses. (A and B) Histoimmunofluorescence detection and
quantitation of active Akt (A) and active caspase-3 (B). Results correspond to the mean  95% CI of measurements performed on 4 to 6 animals (three
independent experiments). (C) Western blot analysis of RasGAP cleavage (the blot shown is representative of three independent experiments). (D) Assessment
of apoptosis by the TUNEL assay. Results correspond to the mean 95% CI of measurements performed on 5 to 9 animals (three independent experiments).
(E) Histological assessment of sunburn cells in the epidermis. Results correspond to the mean 95% CI of measurements performed on 9 to 11 animals (three
independent experiments). Cells indicated by light blue arrowheads are enlarged in the insets. Bar, 20 m.
FIG 7 Role of RasGAP cleavage in heart of doxorubicin-treated mice. Wild-type (WT) and RasGAPD455A/D455A (KI) mice were injected with doxorubicin and
analyzed 5 days later. (A)Western blot analysis of RasGAP cleavage. This experiment has been repeated once with similar results. (B) Histoimmunofluorescence
detection and quantitation of active Akt. Bar, 100 m. (C) Assessment of apoptosis by the TUNEL assay. (B and C) Results correspond to the mean 95% CI
ofmeasurements performed on 3 animals per condition (three independent experiments). (D) Representative examples of end-systolic left ventricular pressure-
volume loops. (E)Heart contractility assessed by end-systolic elastance. Results correspond to themean 95%CI ofmeasurements performedon 9 to 11 animals
per condition (three independent experiments).
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activation induced by low stresses (Fig. 1 and 2). Therefore,
caspase-3 exerts an important protective function in tissues and
organs in a RasGAP cleavage-dependent manner under condi-
tions where caspase-3 activation may be below the detection
threshold of current caspase-3 activation assessment methods.
In conclusion, our study provides the first genetic evidence that
in response to various pathology-inducing stresses caspase-3 itself
activates the antiapoptotic Akt kinase and that this protective re-
sponse is mediated through the cleavage of a given caspase-3 sub-
strate, the ubiquitous p120 RasGAP protein. This defense mech-
anism allows an organism to dampen damage to tissues and
organs induced by diverse pathogenic conditions. Hence, proce-
dures aimed at activating the signaling pathways modulated by
RasGAP cleavage may represent an attractive strategy to increase
the resistance of individuals exposed to environmental or chemi-
cal stresses. Additionally, our work has direct implications for
therapeutic protocols using caspase inhibitors, as inhibition of
caspases could lead to unanticipated adverse effects by decreasing
the ability of an organism to cleave RasGAP and defend itself.
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